{
    "nctId": "NCT03070236",
    "briefTitle": "PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions",
    "officialTitle": "PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 912,
    "primaryOutcomeMeasure": "The Primary Outcome Measures Severity of Chronic Pain.",
    "eligibilityCriteria": "Inclusion Criteria:\n\nPatients treated at DUMC, DFCI, MDACC, MGH, NWH, or DFCI @ SSH with a diagnosis of DCIS, LCIS, ADH, or ALH who are also:\n\n* Age 18 or more at index diagnosis\n* Diagnosed with DCIS, LCIS, ADH, or ALH between January 1, 2012 and June 30, 2017\n* Able to read either English or Spanish and able to provide written (via paper), or on-line informed consent\n* Treated and followed at one of the study sites (including affiliated network sites) and for whom treatment and surveillance data are available, for at least 1 year of follow up after date of diagnosis\n* Participants with bilateral synchronous or metachronous disease (DCIS, LCIS, ADH, ALH) are eligible\n\nExclusion Criteria:\n\n* Ever had a diagnosis of invasive or microinvasive breast cancer\n* DCIS prior to index lesion or history of progressive/recurrent DCIS after treatment\n* Other cancers (excluding non-melanoma skin cancer) diagnosed within 5 years prior to index lesion, including concurrent invasive cancer diagnosis and up to the present time of participant's approach to invitation into the study\n* Patients identified by treating physician as being unsuitable for contact",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}